Tim Wang, M.D. is an Orthopaedic Surgeon at Stanford Healthcare specializing in Sports Medicine. Dr. Wang sees patients and performs surgeries at the Stanford Medicine Outpatient Center in Redwood City and Stanford Healthcare in Emeryville.

Dr. Wang?s clinical expertise includes the management of sports injuries of the knee, shoulder, and elbow using the most innovative arthroscopic and minimally invasive techniques. He has particular interest in knee cartilage regeneration, cartilage transplantation, and knee ligament reconstruction. He also provides comprehensive shoulder care (including rotator cuff tears and shoulder replacement), as well as treats fractures of the upper and lower extremities.

Originally from Chicago, Dr. Wang recognized his passion for medicine early in his career and committed to the Honors Program in Medical Education at Northwestern University. He continued his training at the Northwestern University Feinberg School of Medicine. In recognition of his academic achievements, Dr. Wang was elected to the Alpha Omega Alpha honors society and also received his medical degree with Distinction in Research. He completed his orthopaedic surgery residency at Stanford University and went on to pursue subspecialty training in Sports Medicine and Shoulder Surgery at the Hospital for Special Surgery in New York, the top ranked Orthopaedic hospital in the nation. While in New York, he served as the Clinical Fellow for the Brooklyn Nets NBA team and Iona College athletics (NCAA DI MAAC). Dr. Wang has participated in the care of countless collegiate and professional athletes. He currently serves as Team Physician for Laney College and Merritt College in Oakland.


Clinical Focus

  • Orthopaedic Surgery
  • Sports Medicine
  • Knee Surgery
  • Shoulder Surgery

Academic Appointments

Professional Education

  • Board Certification: American Board of Orthopaedic Surgery, Orthopaedic Surgery (2019)
  • Fellowship: Hospital for Special Surgery and Cornell Univ Med Coll (2017) NY
  • Residency: Stanford University Orthopaedics (2016) CA
  • Medical Education: Northwestern University Feinberg School of Medicine (2011) IL


All Publications

  • Patellofemoral Cartilage Lesions Treated With Particulated Juvenile Allograft Cartilage: A Prospective Study With Minimum 2-Year Clinical and Magnetic Resonance Imaging Outcomes ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY Wang, T., Belkin, N. S., Burge, A. J., Chang, B., Pais, M., Mahony, G., Williams, R. J. 2018; 34 (5): 1498?1505


    To analyze the functional outcomes of patients treated with particulated juvenile articular cartilage (PJAC) for symptomatic articular cartilage lesions in the patellofemoral joint, correlates clinical outcomes with magnetic resonance imaging (MRI) appearance of the repair tissue using cartilage-sensitive quantitative T2-mapping.All patients treated with PJAC for patellofemoral lesions were identified and prospectively followed with clinical outcome scores (International Knee Documentation Committee [IKDC], Knee Outcome Survey-Activities of Daily Living [KOS-ADL], and Marx Activity Scale [MAS]). Postoperative MRI scans using quantitative T2 mapping were obtained and interpreted by an independent musculoskeletal radiologist.Twenty-seven patients treated with PJAC for 30 full-thickness patellofemoral cartilage lesions were identified; mean postoperative follow-up was 3.84 years. Improvements from pre- to postoperative mean IKDC (45.9 vs 71.2, P < .001) and KOS-ADL (60.7 vs 78.8, P < .001) scores were observed; no significant change in MAS was seen (7.04 vs 7.17, P = .97). Advanced age, history of previous surgery, lesion location (patella vs trochlea), or concomitant tibial tubercle osteotomy did not affect outcome scores. Greater body mass index was associated with less improvement in KOS-ADL score. No patients required reoperation for graft-related issues. Lesion fill exceeding 67% by MRI assessment was noted in 69.2% of lesions; depth of lesion fill did not correlate with clinical outcomes. Quantitative T2-mapping revealed prolonged relaxation time at the graft site compared with adjacent normal cartilage at both deep and superficial zones.This study found significantly improved pain and function in patients treated with PJAC for symptomatic patellofemoral articular cartilage defects. No patients required reoperation for graft-related issues. Postoperative MRI revealed majority lesion fill in more than 69% of patients, but persistent morphologic differences between graft site and normal adjacent cartilage remain. Though we support PJAC use in this setting to improve patient subjective outcomes, improved appearance on postoperative imaging was not found to provide additional clinical benefit.Level IV, case series.

    View details for DOI 10.1016/j.arthro.2017.11.021

    View details for Web of Science ID 000432162600025

    View details for PubMedID 29395552

  • Endoscopic-assisted epiphysiodesis: technique and 20-year experience. Journal of pediatric orthopedics. Part B Ledesma, J. B., Wang, T., Desmond, E., Imrie, M., Gamble, J. G., Rinsky, L. A. 2016; 25 (1): 24-30


    The aim of the study was to describe the endoscopic-assisted epiphysiodesis technique and review our 20-year experience with it. A retrospective review of 44 patients who underwent proximal tibia and/or distal femur endoscopic-assisted epiphysiodesis was carried out. Only patients who had preoperative and postoperative scanograms with clinical follow-up of at least 6 months were included. The mean length of follow-up was 36.8 months. All patients had radiographic evidence of physeal fusion within 6-12 months from the index procedure. No patient required revision surgery. Endoscopic-assisted epiphysiodesis is safe, effective, and achieves predictable physeal fusion. Advantages over current techniques include reduced radiation exposure and lack of requirement for hardware placement.

    View details for DOI 10.1097/BPB.0000000000000230

    View details for PubMedID 26462167

Footer Links:

Stanford Medicine Resources: